Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
bore, bound, Broaden, centralized, classification, compressed, CRSP, cut, dedicated, Deirdre, derecognition, disclose, diversity, Error, ESPP, EU, forecast, GAAP, Gillespie, guidance, improper, interaction, intrinsic, Koch, lapsed, likelihood, Lisa, Mexico, Michael, ofForm, pipeline, preapproval, principle, pronouncement, quantifying, refile, reinvested, replacement, requisite, resignation, sheet, SIC, Similarly, simplified, synergestic, Tansey, timeframe, title, unexpected, unrecognized, unusual, venture, virtually
Removed:
absence, Accountant, accumulation, activation, active, Adjunct, adjustment, advanced, affecting, Affymax, al, alternate, amine, anticoagulant, antigen, antiphospholipid, arrest, arterial, attach, attacked, authority, avoiding, awarded, azathioprine, bacteria, Baltimore, Beach, Berkeley, beta, Bible, bind, BIOCOM, biological, biologically, Biology, biomedical, bleeding, bodily, body, brain, breakdown, broadly, Buffalo, cardiolipin, cardiovascular, carefully, categorized, Catholic, cease, Certified, cessation, chemical, chemotherapy, chose, Christian, Cincinnati, Clinic, closed, clotting, collecting, collectively, College, commitment, composed, composite, concur, concurrent, Conference, conjugate, consisting, consumption, Controller, CPA, cyclosporin, debilitating, decorative, deep, defense, destruction, developer, diagnostic, Divisional, documented, domain, double, Dow, Duke, Electron, eliminating, elimination, emotional, engineering, episode, equivalent, Ernst, escalating, evidenced, excluded, exhibited, expensed, experimental, explain, explore, extension, factor, favor, Fellow, fetal, field, fighting, formation, forward, France, frequency, functioning, fundamental, Glaxo, GPI, harmful, Harvard, head, hemolytic, heparin, highest, Hoechst, home, Hong, Hospital, hospitalized, HRQOL, hypertension, identified, immunity, immunology, improvement, inducing, initiation, input, Institute, Instructor, instrument, interconnectivity, interfering, Inverse, joining, Kendall, knowledge, Kong, lab, larger, Lawrence, Leader, leflunomide, lighting, linking, literature, LLP, lodge, long, Losing, malfunctioning, Mallinckrodt, Manager, mandated, Marion, Maryland, maternal, maximize, McGaw, measured, mechanism, medically, medicine, mental, Merrell, mice, Micro, mimic, minimize, minimizing, mirror, Missouri, moderate, modifying, mofetil, molding, Mulay, muscular, myasthenia, mycophenolate, nausea, neurological, Neurology, neuromuscular, Neurosurgery, Nicotrol, Nobel, Obispo, occurrence, optimization, optimized, organ, original, oxidase, pain, parallel, participate, participated, patch, pathogenic, Pepperdine, Peptide, percentage, Pharmacologist, physical, Physiology, placenta, Plastic, Polytechnic, Postdoctoral, Power, pp, pre, prednisone, preferentially, prescribed, prescribing, presenting, privately, Prize, producing, Professor, progressed, progressing, progressive, Project, promote, promoted, protective, Psychology, publicly, purified, purifying, Quantum, Quidel, ratio, recognizing, recommended, recurrent, recurring, red, region, regional, regular, regulate, rejection, released, reliable, replicated, respiratory, resurfacing, Rh, rid, Roussel, School, science, Scientist, scoring, selecting, selectively, Seminary, sense, separating, served, serving, shut, signal, skin, smoking, social, Society, Solectek, sooner, Southern, specificity, SRI, stable, step, sterility, stranded, strongly, suggest, suggested, suggesting, Sulzer, Summit, suppression, surface, surgery, survive, survivor, susceptible, sustaining, Symposium, syndrome, synthesize, synthesized, Taipei, Taiwan, Thermo, ThermoLase, thrombotic, tissue, Toleragen, tolerize, tolerized, toxic, transdermal, transient, transplant, trend, true, unblinded, unique, University, Va, variety, vehicle, vein, visit, vital, vitality, warfarin, wasting, weight, Wellcome, worked, World, worldwide, worsened, xenotransplantation, York, Zoology
Filing tables
Filing exhibits
Related press release
LJPC similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-106060, 333-116233, 333-131248 and 333-125427 and Form S-3 Nos. 333-101499, 333-31142, 333-43066, 333-55370, 333-81432 and 333-131246) of La Jolla Pharmaceutical Company and in the related Prospectuses of our reports dated March 7, 2007, with respect to: (1) the consolidated financial statements of La Jolla Pharmaceutical Company, and (2) La Jolla Pharmaceutical Company management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of La Jolla Pharmaceutical Company, included in this Annual Report (Form 10-K) for the year ended December 31, 2006.
/s/ Ernst & Young LLP | ||||
San Diego, California
March 13, 2007
March 13, 2007